Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.03 | 0.8 |